BUSINESS SEGMENT INFORMATION (Major Customers) (Details)	12 Months Ended
Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
McKesson Corporation [Member]
Concentration Risk [Line Items]
Gross sales to three largest pharmaceutical wholesalers in the U.S., percentage of total gross sales	23.00%	26.00%	24.00%
Cardinal Health, Inc. [Member]
Concentration Risk [Line Items]
Gross sales to three largest pharmaceutical wholesalers in the U.S., percentage of total gross sales	19.00%	21.00%	21.00%
Amerisourcebergen Corporation [Member]
Concentration Risk [Line Items]
Gross sales to three largest pharmaceutical wholesalers in the U.S., percentage of total gross sales	14.00%	16.00%	16.00%

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13531-108611

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration